Cancer
WT1 Peptide Pool, human
€285.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Caution:
For research use only. Not for use in humans.
1
Product number: LB01471
Description
Peptide pool of 110 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Wilms tumor protein (WT33) (Swiss-Prot ID: P19544) of Homo sapiens (Human) for T cell assays (e.g. ELISPOT).
One unit allows the stimulation of 2,5 x 108 cells.
You can find applications and references in our blog:
FACS analysis showed: CMV-specific T cells respond to leukemia antigen >
TechData
| Gene: | WT1 |
| Delivery: | 1-3 days |
| Counterion: | TFA |
| Length: | 449 amino acids |
| No. Peptides: | 110 peptides |
| Amount/Aliquote: | 15 nmol (approx. 25µg)/peptide for stimulation of 2,5 x 108 cells |
| Solubility: | Dissolve in a minimum amount of pure DMSO (40µl) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system. |
| Protein: | Wilms tumor protein |
| UniProt Id: | P19544 |
| Species: | Human |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Cancer |
Documents
References
Luo, Xiao-Hua et al. “Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse.” Frontiers in immunology vol. 13 1027593. 7 Feb. 2023, doi:10.3389/fimmu.2022.1027593